Serum In­sti­tute of In­dia in talks to se­cure a fill-fin­ish deal for the Ox­ford malar­ia vac­cine in Ghana

The vac­cine man­u­fac­tur­er Serum In­sti­tute of In­dia is look­ing to es­tab­lish fill-fin­ish op­er­a­tions in Ghana for the new­ly ap­proved Ox­ford R21 malar­ia vac­cine.

The Serum …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER